Measurable Residual Disease-Driven Approach to Frontline Treatment for Chronic Lymphocytic Leukemia in Younger and/or Fit Patients. // Advances in Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2666853X26000159?dgcid=rss_sd_all
Measurable Residual Disease-Driven Approach to Frontline Treatment for Chronic Lymphocytic Leukemia in Younger and/or Fit Patients. Advances in Oncology. https://www.sciencedirect.com/science/article/pii/S2666853X26000159?dgcid=rss_sd_all
“Measurable Residual Disease-Driven Approach to Frontline Treatment for Chronic Lymphocytic Leukemia in Younger and/or Fit Patients.” Advances in Oncology.
@article{article33488,
title = {Measurable Residual Disease-Driven Approach to Frontline Treatment for Chronic Lymphocytic Leukemia in Younger and/or Fit Patients},
journal = {Advances in Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2666853X26000159?dgcid=rss_sd_all}
}